Skip to main content

Evaluation and Management of Lacrimal Gland Diseases

  • Chapter
  • First Online:
Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery

Abstract

The lacrimal gland is the epicenter of a broad spectrum of neoplastic and inflammatory diseases (Table 58.1). Space occupying lesions of the lacrimal gland and its fossa constitute approximately 5–13% of orbital masses upon biopsy [1–3]. Based primarily on Reese’s [4] 1956 clinicopathologic survey of 112 consecutive expanding lesions of the lacrimal gland, most authorities generally report that approximately 50% of the lesions originate from epithelial elements of the lacrimal gland and 50% are of non-epithelial origin [5–7]. Of non-epithelial lesions, 50% are lymphoid tumors and 50% are comprised of various infections and inflammatory pseudotumors. Among the epithelial tumors of the lacrimal gland, approximately 50% are pleomorphic adenomas (benign mixed tumors), 25% adenoid cystic carcinoma, and the remainders are other types of carcinoma. Recent reports, however, suggest that inflammatory lesions and lymphoid tumors are more common, and that epithelial malignancies of the lacrimal gland are considerably less frequent than commonly cited, ranging from 22% to 47% [1, 3, 7–10]. Proper differentiation between these two groups is of paramount importance since several of the lesions are life threatening.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Shields JA, Bakewell B, Augsburger JJ, Flanagan JC. Classification and incidence of space-occupying lesions of the orbit: a survey of 645 biopsies. Arch Ophthalmol. 1984;102:1606–11.

    CAS  PubMed  Google Scholar 

  2. Reese AB. Expanding lesions of the orbit. Bowman lecture. Trans Ophthalmol Soc UK. 1971;91:85–104.

    CAS  PubMed  Google Scholar 

  3. Kennedy RE. An evaluation of 820 orbital cases. Trans Am Ophthalmol Soc. 1984;82:134–57.

    CAS  PubMed Central  PubMed  Google Scholar 

  4. Reese AB. The treatment of expanding lesions of the orbit: with particular regard to those arising in the lacrimal gland. The seventh Arthur J Bedell lecture. Am J Ophthalmol. 1956;41:3–11.

    CAS  PubMed  Google Scholar 

  5. Font RL, Gamel JW. Adenoid cystic carcinoma of the lacrimal gland: a clinicopathologic study of 79 cases. In: Nicholson DH, editor. Ocular pathology update. New York: Mason; 1980. p. 271–5.

    Google Scholar 

  6. Goder GJ. Tumours of the lacrimal gland. Orbit. 1982;1:91–6.

    Google Scholar 

  7. Rootman J. Diseases of the orbit: a multidisciplinary approach. Philadelphia: Lippincott; 1988. p. 384–405.

    Google Scholar 

  8. Shields CL, Shields JA, Eagle RC, Rathwell JP. Clinicopathologic review of 142 cases of lacrimal gland lesions. Ophthalmology. 1989;96:431–5.

    CAS  PubMed  Google Scholar 

  9. Jakobiec FA, Font RL. Orbit. In: Spencer WH, editor. Ophthalmic pathology: an atlas and textbook, vol. 3. 3rd ed. Philadelphia: WB Saunders; 1986. p. 2496–525.

    Google Scholar 

  10. Stewart WB, Krohel GB, Wright JE. Lacrimal gland and fossa lesions: an approach to diagnosis and management. Ophthalmology. 1979;86:886–95.

    CAS  PubMed  Google Scholar 

  11. Wright JE, Ross GE, Garner A. Primary malignant neoplasms of the lacrimal gland. Br J Ophthalmol. 1992;76:401.

    CAS  PubMed Central  PubMed  Google Scholar 

  12. Hurwitz JJ. A practical approach to the management of lacrimal gland lesions. Ophthalmic Surg. 1982;13:829.

    CAS  PubMed  Google Scholar 

  13. Wright JE, Stewart WB, Krohel GB. Clinical presentation and management of lacrimal gland tumours. Br J Ophthalmol. 1979;63:600–6.

    CAS  PubMed Central  PubMed  Google Scholar 

  14. Font RL, Smith SL, Bryan RG. Malignant epithelial tumors of the lacrimal gland: a clinicopathologic study of 21 cases. Arch Ophthalmol. 1998;116:613.

    CAS  PubMed  Google Scholar 

  15. Jakobiec FA. Tumors of the lacrimal gland and lacrimal sac. In: Symposium on diseases and surgery of the lids, lacrimal apparatus, and orbit. Transactions of the New Orleans Academy of Ophthalmology. St. Louis: CV Mosby; 1982. pp.190–202.

    Google Scholar 

  16. Milder B. Diseases of the lacrimal gland. In: Milder B, Weil BA, editors. The lacrimal system. Norwalk: Appleton-Century-Croft; 1983. p. 105–10.

    Google Scholar 

  17. Tychsen L, Tse DT, Ossoinig K, Anderson RL. Trochleitis with superior oblique myositis. Ophthalmology. 1984;91:1075–9.

    CAS  PubMed  Google Scholar 

  18. Rootman J, Nugent R. The classification and management of acute orbital pseudotumors. Ophthalmology. 1982;89:1040–8.

    CAS  PubMed  Google Scholar 

  19. Rootman J, McCarthy V, et al. Idiopathic sclerosing inflammation of the orbit: a distinct clinicopathologic entity. Ophthalmology. 1994;101:570–84.

    CAS  PubMed  Google Scholar 

  20. Mombaerts I, Schlingemann RO, Goldschmeding R, et al. The surgical management of lacrimal gland pseudotumors. Ophthalmology. 1996;103:1619–27.

    CAS  PubMed  Google Scholar 

  21. Pepose JS, Akata RF, Pflugfelder SC, et al. Mononuclear cell phenotypes and immunoglobulin gene rearrangements in lacrimal gland biopsies from patients with Sjögren’s syndrome. Ophthalmology. 1990;97:1599–605.

    CAS  PubMed  Google Scholar 

  22. Pflugfelder SC, Tseng SCG, Pepose JS, et al. Epstein-Barr virus infection and immunologic dysfunction in patients with aqueous tear deficiency. Ophthalmology. 1990;97:313–23.

    CAS  PubMed  Google Scholar 

  23. Bell M, Askari A, Bookman A, et al. Sjögren’s syndrome: a critical review of clinical management. J Rheumatol. 1999;26:2051–61.

    CAS  PubMed  Google Scholar 

  24. Obenauf CD, Shaw HE, Sydnor CF, et al. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol. 1978;86:648–55.

    CAS  PubMed  Google Scholar 

  25. Weinreb RN, Yavitz EQ, O’Connor GR. Lacrimal gland uptake of gallium citrate Ga 67. Am J Ophthalmol. 1981;92:16–20.

    CAS  PubMed  Google Scholar 

  26. Weinreb RN. Diagnosing sarcoidosis by transconjunctival biopsy of the lacrimal gland. Am J Ophthalmol. 1984;97:573–6.

    CAS  PubMed  Google Scholar 

  27. Cook JR, Brubaker RF, Savell J, et al. Lacrimal sarcoidosis treated with corticosteroids. Arch Ophthalmol. 1972;88:513–7.

    CAS  PubMed  Google Scholar 

  28. Robin JB, Schanzlin DJ, Meisler DM, et al. Ocular involvement in the respiratory vasculitides. Surv Ophthalmol. 1985;30:127–40.

    CAS  PubMed  Google Scholar 

  29. Leavitt JA, Butrus SI. Wegener’s granulomatosis presenting as dacryoadenitis. Cornea. 1991;10:542–5.

    CAS  PubMed  Google Scholar 

  30. Perry SR, Rootman J, White VA. The clinical and pathologic constellation of Wegener granulomatosis of the orbit. Ophthalmology. 1997;104:683–94.

    CAS  PubMed  Google Scholar 

  31. Nguyen QD, Foster CS. Systemic lupus erythematosus and the eye. Int Ophthalmol Clin. 1998;38:33–60.

    CAS  PubMed  Google Scholar 

  32. Brenner EH, Shock JP. Proptosis secondary to systemic lupus erythematosus. Arch Ophthalmol. 1974;91:81–2.

    CAS  PubMed  Google Scholar 

  33. Burkhalter E. Unique presentation of systemic lupus erythematosus. Arthritis Rheum. 1973;16:428.

    CAS  PubMed  Google Scholar 

  34. Trokel SL, Jakobiec FA. Correlation of CT scanning and pathologic features of ophthalmic Graves’ disease. Ophthalmology. 1981;88:553–64.

    CAS  PubMed  Google Scholar 

  35. Jakobiec FA, Iwamoto T. The ocular adnexa. In: Jakobiec F, editor. Ocular anatomy. Embryology, and teratology. Philadelphia: Harper & Row; 1982. p. 677–732.

    Google Scholar 

  36. Wieczorek R, Jakobiec FA, Sacks EH, et al. The immunoarchitecture of the normal lacrimal gland: relevancy for understanding pathologic conditions. Ophthalmology. 1988;95:100–9.

    CAS  PubMed  Google Scholar 

  37. Sacks EH, Wieczorek R, Jakobiec FA, et al. Lymphocytic subpopulations in the normal human conjunctiva: a monoclonal antibody study. Ophthalmology. 1986;93:459–71.

    Google Scholar 

  38. Rubin PAD, Kent CJ, Jakobiec FA. Orbital and ocular adnexal lymphoid tumors. In: Albert DM, Jakobiec FA, editors. Principles and practice of ophthalmology, vol. 4. Philadelphia: WB Saunders; 1994. p. 3182–97.

    Google Scholar 

  39. Jakobiec FA, Yeo JH, Trokel SL, et al. Combind clinical and computed tomographic diagnosis of primary lacrimal fossa lesions. Am J Ophthalmol. 1982;94:785–807.

    CAS  PubMed  Google Scholar 

  40. Shields CL, Shields JA, Eagle RC, Rathmell JP. Clinicopathologic review of 142 cases of lacrimal gland lesions. Ophthalmology. 1989;96:431.

    CAS  PubMed  Google Scholar 

  41. White V, Rootman J, Quenville N, et al. Orbital lymphoproliferative and inflammatory lesions. Can J Ophthalmol. 1987;22:362.

    CAS  PubMed  Google Scholar 

  42. Rootman J, Robertson W, LaPointe JS, White V. Lymphoproliferative and leukemic lesions. In: Rootman J, editor. Diseases of the orbit. A multidisciplinary approach. Philadelphia: JB Lippincott; 1988. p. 205–40.

    Google Scholar 

  43. White WL, Ferry JA, Harris NL, et al. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology. 1995;102:1994–2006.

    CAS  PubMed  Google Scholar 

  44. Fung CY, Tarbell NJ, Lucarelli MJ, et al. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes. Int J Radiat Oncol Biol Phys. 2003;57:1382–91.

    PubMed  Google Scholar 

  45. McKelvie PA, McNab A, Francis IC, et al. Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clin Exp Ophthalmol. 2001;29:387–93.

    CAS  Google Scholar 

  46. Coupland SE, Hellmich M, Auw-Haedrich C, et al. Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases. Br J Ophthalmol. 2005;89:352–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  47. Jakobiec FA, Knowles DM. An overview of ocular adnexal lymphoid tumors. Trans Am Ophthalmol Soc. 1989;LXXXVII:420–44.

    Google Scholar 

  48. Jakobiec FA, Font RL. Lymphoid tumors. In: Spencer WH, editor. Ophthalmic pathology: an atlas and textbook. Philadelphia: WB Saunders; 1986. p. 2663–712.

    Google Scholar 

  49. Jakobiec FA, McLean I, Font R. Clinicopathologic characteristics of orbital lymphoid hyperplasia. Ophthalmology. 1979;86:948–66.

    CAS  PubMed  Google Scholar 

  50. Ferreri AJ, Guidoboni M, Ponzoni M, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst. 2004;96:586–94.

    PubMed  Google Scholar 

  51. Ruiz A, Reischl U, Swerdlow SH, et al. Extranodal marginal zone B-cell lymphomas of the ocular adnexa: multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci. Am J Surg Pathol. 2007;31:792–802.

    PubMed  Google Scholar 

  52. Decaudin D, de Cremoux P, Vincent-Salomon A, et al. Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood. 2006;108:1451–60.

    CAS  PubMed  Google Scholar 

  53. Mulder MM, Heddema ER, Pannekoek Y, et al. No evidence for an association of ocular adnexal lymphoma with Chlamydia psittaci in a cohort of patients from the Netherlands. Leuk Res. 2006;30:1305–7.

    PubMed  Google Scholar 

  54. Yakushijin Y, Kodama T, Takaoka I, et al. Absence of chlamydial infection in Japanese patients with ocular adnexal lymphoma of mucosa-associated lymphoid tissue. Int J Hematol. 2007;85:223–30.

    CAS  PubMed  Google Scholar 

  55. Gracia E, Froesch P, Mazzucchelli L, et al. Low prevalence of Chlamydia psittaci in ocular adnexal lymphomas from Cuban patients. Leuk Lymphoma. 2007;48:104–8.

    CAS  PubMed  Google Scholar 

  56. Vargas RL, Fallone E, Felgar RE, et al. Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? The University of Rochester experience. Leuk Res. 2006;30:547–51.

    PubMed  Google Scholar 

  57. Daibata M, Nemoto Y, Togitani K, et al. Absence of Chlamydia psittaci in ocular adnexal lymphoma from Japanese patients. Br J Haematol. 2006;132:651–2.

    PubMed  Google Scholar 

  58. Liu YC, Ohyashiki JH, Ito Y, et al. Chlamydia psittaci in ocular adnexal lymphoma: Japanese experience. Leuk Res. 2006;30:1587–9.

    CAS  PubMed  Google Scholar 

  59. Husain A, Roberts D, Pro B, et al. Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics. Cancer. 2007;110:809–15.

    PubMed  Google Scholar 

  60. Morgensztern D, Rosado MF, Serafini AN, et al. Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximab. Leuk Lymphoma. 2004;45:1275–8.

    CAS  PubMed  Google Scholar 

  61. Conconi A, Martinelli G, Thieblemont C, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood. 2003;102:2741–5.

    CAS  PubMed  Google Scholar 

  62. Nuckel H, Meller D, Steuhl KP, et al. Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva. Eur J Haematol. 2004;73:258–62.

    PubMed  Google Scholar 

  63. Yoon JS, Ma KT, Kim SJ, et al. Prognosis for patients in a Korean population with ocular adnexal lymphoproliferative lesions. Ophthal Plast Reconstr Surg. 2007;23:94–9.

    PubMed  Google Scholar 

  64. Ferreri AJ, Ponzoni M, Martinelli G, et al. Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa. Haematologica. 2005;90:1578–9.

    CAS  PubMed  Google Scholar 

  65. Ni C, Cheng SC, Dryja TP, Cheng TY. Lacrimal gland tumors: a clinicopathological analysis of 160 cases. Int Ophthalmol Clin. 1982;22:99–120.

    CAS  PubMed  Google Scholar 

  66. Auran J, Jakobiec FA, Krebs W. Benign mixed tumor of the palpebral lobe of the lacrimal gland. Ophthalmology. 1988;95:90–9.

    CAS  PubMed  Google Scholar 

  67. Bech K, Jensen OA. Mixed tumor of the lower orbital region. Arch Ophthalmol. 1965;74:226–8.

    CAS  PubMed  Google Scholar 

  68. Mueller EC, Borit A. Aberrant lacrimal gland and pleomorphic adenoma within the muscle cone. Ann Ophthalmol. 1979;11:661–3.

    CAS  PubMed  Google Scholar 

  69. Mindlin A, Lambert D, Barsky D. Mixed lacrimal gland tumor arising from ectopic lacrimal gland tissue in the orbit. J Pediatr Ophthalmol. 1977;14:44–7.

    CAS  PubMed  Google Scholar 

  70. Murphy MB, Rodriques MM. Benign mixed tumor of the (palpebral) lacrimal gland presenting as a nodular eyelid lesion. Am J Ophthalmol. 1974;77:108–11.

    CAS  PubMed  Google Scholar 

  71. Jakobiec FA, Font RL. Orbit. In: Spencer WH, Font RL, Green WR, et al., editors. Ophthalmic pathology. an atlas and textbook, vol. 3. 3rd ed. Philadelphia: WB Saunders; 1986. p. 2459–860.

    Google Scholar 

  72. Rootman J, Robertson WD. Tumors. In: Rootman J, editor. Diseases of the orbit. Philadelphia: JB Lippincott; 1988.

    Google Scholar 

  73. Font RL, Gamel JW. Epithelial tumors of the lacrimal gland: analysis of 265 cases. In: Jakobiec FA, editor. Ocular and adnexal tumors. Birmingham: Aesculapius; 1978. p. 787–805.

    Google Scholar 

  74. McPherson Jr SD. Mixed tumor of the lacrimal gland: in a seven-year-old boy. Am J Ophthalmol. 1966;61:561–3.

    PubMed  Google Scholar 

  75. Rose ER, Wright JE. Pleomorphic adenoma of the lacrimal gland. Br J Ophthalmol. 1992;76:395.

    CAS  PubMed Central  PubMed  Google Scholar 

  76. Wright JE, Rose GE, Garner A. Primary malignant neoplasms of the lacrimal gland. Br J Ophthalmol. 1992;76:401.

    CAS  PubMed Central  PubMed  Google Scholar 

  77. Tse DT, Folberg R. Technique for incisional biopsy of a lacrimal gland mass when the diagnosis of benign mixed tumor cannot be excluded clinically. Ophthalmic Surg. 1988;19:321–4.

    CAS  PubMed  Google Scholar 

  78. Font RL, Garner A. Myoepithelioma of the lacrimal gland: Report of a case with spindle cell morphology. Br J Ophthalmol. 1992;76:634–6.

    CAS  PubMed Central  PubMed  Google Scholar 

  79. Grossniklaus HE, Wojno TH, Wilson MW, et al. Myoepithelioma of the lacrimal gland. Arch Ophthalmol. 1997;115:1588–90.

    CAS  PubMed  Google Scholar 

  80. Biggs SL, Font RL. Oncocytic lesions of the caruncle and other ocular adnexa. Arch Ophthalmol. 1977;95:474–8.

    CAS  PubMed  Google Scholar 

  81. Wright JE. Factors affecting the survival of patients with lacrimal gland tumours. Can J Ophthalmol. 1982;17:3–9.

    CAS  PubMed  Google Scholar 

  82. Lee DA, Campbell RJ, Waller RR, et al. A clinicopathologic study of primary adenoid cystic carcinoma of the lacrimal gland. Ophthalmology. 1985;92:128–34.

    CAS  PubMed  Google Scholar 

  83. Gamel JW, Font RL. Adenoid cystic carcinoma of the lacrimal gland: the clinical significance of a basaloid histologic pattern. Hum Pathol. 1982;13:219–25.

    CAS  PubMed  Google Scholar 

  84. Tellado MV, McLean JW, Specht CS, Varga J. Adenoid cystic carcinoma s of the lacrimal gland in childhood and adolescence. Ophthalmology. 1997;104:1622–5.

    CAS  PubMed  Google Scholar 

  85. Shields JA, Shields CL, Eagle Jr RC, et al. Adenoid cystic carcinoma developing in the nasal orbit. Am J Ophthalmol. 1997;123:398–9.

    CAS  PubMed  Google Scholar 

  86. Shields JA, Shields CL, Eagle Jr RC, et al. Adenoid cystic carcinoma of the lacrimal gland simulating a dermoid cyst in a 9-year-old boy. Arch Ophthalmol. 1998;116:1673–6.

    CAS  PubMed  Google Scholar 

  87. Wharton JACL, O’Donnell BA. Unusual presentations of pleomorphic adenoma and adenoid cystic carcinoma of the lacrimal gland. Aust N Z J Ophthalmol. 1999;27:145–8.

    CAS  PubMed  Google Scholar 

  88. Tse DT, Benedetto P, Dubovy S, Schiffman JC, Feuer WJ. Clinical analysis of the efect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma. Am J Ophthalmol. 2006;141:44–53.

    CAS  PubMed  Google Scholar 

  89. Duke TG, Fahy GT, Brown LJR. Adenoid cystic carcinoma of the superonasal conjunctival fornix. Orbit. 2000;19:31–5.

    PubMed  Google Scholar 

  90. Henderson JW, Campell RJ, Farrow GM, Garrity JA. Orbital tumors. 3rd ed. New York: Raven; 1994. p. 323–42.

    Google Scholar 

  91. Kiratli H, Bilgic S. An unusual clinical course of adenoid cystic carcinoma of the lacrimal gland. Orbit. 1999;18:197–201. 91.

    PubMed  Google Scholar 

  92. Günalp I, Gündüz K. Epithelial tumors of the lacrimal gland. Orbit. 1994;13:147–54.

    Google Scholar 

  93. Tse DT, Benedetto P, Morcos JJ, Johnson TE, Weed D, Dubovy S. An atypical presentation of adenoid cystic carcinoma of the lacrimal gland. Am J Ophthalmol. 2006;141:187–9.

    PubMed  Google Scholar 

  94. Saini JS, Mohan K, Khandalavala B. Primary radiotherapy in adenoid cystic carcinoma of the lacrimal gland. Orbit. 1990;9:107–11.

    Google Scholar 

  95. Asikin Natanegara IAA, Koornneef L, Veenhof K, et al. An alternative approach for the management of adenocystic carcinoma of the lacrimal gland. Orbit. 1990;9:101–5.

    Google Scholar 

  96. Polito E, Leccisotti A. Epithelial malignancies of the lacrimal gland: survival rates after extensive and conservative therapy. Ann Ophthalmol. 1993;25:422–6.

    CAS  PubMed  Google Scholar 

  97. Tyl JWM, Blank LECM, Koornneef L. Brachytherapy in orbital tumors. Ophthalmology. 1997;104:1475–9.

    CAS  PubMed  Google Scholar 

  98. Buchholz TA, Shimotakahara SG, Weymuller Jr EA, et al. Neutron radiotherapy for adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1993;119:747–52.

    CAS  PubMed  Google Scholar 

  99. Douglas JG, Laramore GE, Austin-Seymour M, et al. Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy. Int J Radiat Oncol Biol Phys. 2000;46:551–7.

    CAS  PubMed  Google Scholar 

  100. Byers RM, Berkeley RG, Luna M, Jesse RH. Combined therapeutic approach to malignant lacrimal gland tumors. Am J Ophthalmol. 1975;79:53–5.

    CAS  PubMed  Google Scholar 

  101. Henderson JW, Neault RW. En bloc removal of intrinsic neoplasms of the lacrimal gland. Am J Ophthalmol. 1976;82:905–9.

    CAS  PubMed  Google Scholar 

  102. Rootman J, Lapointe JS. Tumors of the lacrimal gland. In: Rootman J, editor. Diseases of the orbit; a multidisciplinary approach. Philadelphia: JB Lippincott; 1988. p. 384–95.

    Google Scholar 

  103. Marsh JL, Wise DM, Smith M, Schwartz H. Lacrimal gland adenoid cystic carcinoma: intracranial and extracranial en bloc resection. Plast Reconstr Surg. 1981;68:577–85.

    CAS  PubMed  Google Scholar 

  104. Janecka I, Housepian E, Trokel S, et al. Surgical management of malignant tumors of the lacrimal gland. Am J Surg. 1984;148:539–41.

    CAS  PubMed  Google Scholar 

  105. Henderson JW. Adenoid cystic carcinoma of the lacrimal gland, is there a cure? Trans Am Ophthalmol Soc. 1987;85:312–4; discussion 314–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  106. Henderson JW. Past, present, and future surgical management of malignant epithelial neoplasms of the lacrimal gland. Br J Ophthalmol. 1986;70:727–31.

    CAS  PubMed Central  PubMed  Google Scholar 

  107. Ashton N. Epithelial tumours of the lacrimal gland. Mod Probl Ophthalmol. 1975;14:306–23.

    CAS  PubMed  Google Scholar 

  108. Zimmerman LE, Sanders TE, Ackerman LV. Epithelial tumors of the lacrimal gland: prognostic and therapeutic significance of histologic types. Int Ophthalmol Clin. 1962;2:337–67.

    Google Scholar 

  109. Esmaeli B, Ahmadi MA, Youssef A, et al. Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland. Ophthal Plast Reconstr Surg. 2004;20:22–6.

    PubMed  Google Scholar 

  110. Bartley GB, Harris GJ. Adenoid cystic carcinoma of the lacrimal gland: is there a cure…yet? Ophthal Plast Reconstr Surg. 2002;18:315–8.

    PubMed  Google Scholar 

  111. Naugle Jr T, Tepper DJ, Haik BG. Adenoid cystic carcinoma of the lacrimal gland: a case report. Ophthal Plast Reconstr Surg. 1994;10:45–8.

    PubMed  Google Scholar 

  112. Meldrum ML, Tse DT, Benedetto P. Neoadjuvant intracarotid chemotherapy for treatment of advanced adenocystic carcinoma of the lacrimal gland. Arch Ophthalmol. 1998;116:315–21.

    CAS  PubMed  Google Scholar 

  113. Sessions RB, Lehane DE, Smith RJ, et al. Intra-arterial cisplatin treatment of adenoid cystic carcinoma. Arch Otolaryngol. 1982;108:221–4.

    CAS  PubMed  Google Scholar 

  114. Suen JY, Johns ME. Chemotherapy for salivary gland cancer. Laryngoscope. 1982;92:235–9.

    CAS  PubMed  Google Scholar 

  115. Tse DT. Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma. Trans Am Ophthalmol Soc. 2005;103:337–67.

    PubMed Central  PubMed  Google Scholar 

  116. Buendia MA. Genetics of hepatocellular carcinoma. Semin Cancer Biol. 2000;10:185–200.

    CAS  PubMed  Google Scholar 

  117. Finkelstein SD, Marsh W, Demetris AJ, et al. Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma. Hepatology. 2003;37:871–9.

    CAS  PubMed  Google Scholar 

  118. Tse DT, Finkelstein SD, Benedetto P, Dubovy S, Schiffman J, Feuer WJ. Microdissection genotyping analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma. Am J Ophthalmol. 2006;141:54–61.

    CAS  PubMed  Google Scholar 

  119. Henderson JW, Farrow GM. Primary malignant mixed tumors of the lacrimal gland. Ophthalmology. 1980;87:466–75.

    CAS  PubMed  Google Scholar 

  120. Shields JA, Shields CL. Malignant transformation of presumed pleomorphic adenoma of lacrimal gland after 60 years. Arch Ophthalmol. 1987;105:1403–5.

    CAS  PubMed  Google Scholar 

  121. Font RL, Patipa M, Rosenbaum PS, Smith S, et al. Correlation of computed tomographic and histopathologic features in malignant transformation of benign mixed tumor of lacrimal gland. Surv Ophthalmol. 1990;34:449–52.

    CAS  PubMed  Google Scholar 

  122. Reese AB. Tumors of the eye. 2nd ed. New York: Harper & Row; 1963. p. 485–506.

    Google Scholar 

  123. Eviatar JA, Hornblass A. Mucoepidermoid carcinoma of the lacrimal gland: 25 cases and a review and update of the literature. OPRS. 1993;9:170–81.

    CAS  Google Scholar 

  124. Pulitzer DR, Echert ER. Mucoepidermoid carcinoma of the lacrimal gland. Arch Ophthalmol. 1987;105:1406–9.

    CAS  PubMed  Google Scholar 

  125. De Rosa G, Zeppa P, Tranfa F, Bonavolonta G. Acinic cell carcinoma arising in a lacrimal gland: first case report. Cancer. 1986;57:1988–91.

    PubMed  Google Scholar 

  126. Rosenbaum PS, Mahadevia PS, Goodman LA, Kress Y. Acinic cell carcinoma of the lacrimal gland. Arch Ophthalmol. 1995;113:781–5.

    CAS  PubMed  Google Scholar 

  127. Hotta K, Arisawa T, Mito H, Narita M. Primary squamous cell carcinoma of the lacrimal gland. Clin Exp Ophthalmol. 2005;33:534–5.

    Google Scholar 

  128. Su GW, Patipa M, Font RL. Primary squamous cell carcinoma arising from an epithelium-lined cyst of the lacrimal gland. Ophthal Plast Reconstr Surg. 2005;21:383–5.

    PubMed  Google Scholar 

  129. Fenton S, Srinivasan S, Harnett A, Brown I. Squamous cell carcinoma of the lacrimal gland. Eye. 2003;17:424–5.

    CAS  PubMed  Google Scholar 

  130. Shields JA, Shields CL, Epstein JA, Scartozzi R. Primary epithelial malignancies of the lacrimal gland: the 2003 Ramon L. Font lecture. Ophthal Plast Reconstr Surg. 2004;20:10–21.

    PubMed  Google Scholar 

  131. Chan WM, Liu DTL, Lam LYM, Choi PCL. Primary epithelial-myoepithelial carcinoma of the lacrimal gland. Arch Ophthalmol. 2004;122:1714–7.

    PubMed  Google Scholar 

  132. Takahira M, Nakamura YM, Shimizu SI, Minato H, et al. Carcinosarcoma of the lacrimal gland arising from a pleomorphic adenoma. Am J Ophthalmol. 2005;140:337–40.

    PubMed  Google Scholar 

  133. Ni C, Kuo KP, Dryja KP. Histopathologic classification of 272 primary epithelial tumors of the lacrimal gland. Chin Med J. 1992;105:481–5.

    CAS  PubMed  Google Scholar 

  134. Brownstein S, Belin MW, Krohel GB, Smith RS, et al. Orbital dacryops. Ophthalmology. 1984;91:1424–8.

    CAS  PubMed  Google Scholar 

  135. Duke-Elder S, editor. System of Ophthalmology, Vol 13, pt 2: The ocular adnexa: lacrimal, orbital and para-orbital diseases. London: Henry Kimpton; 1974. p. 638–43.

    Google Scholar 

  136. Fiander D, Brownstein S, Nicolle D, Jackson WB. Mucosal cyst of lacrimal gland fossa simulating lacrimal gland neoplasm. Can J Ophthalmol. 1980;15:87–90.

    CAS  PubMed  Google Scholar 

  137. Bullock JD, Fleishman JA, Rosset JS. Lacrimal ductal cysts. Ophthalmology. 1986;93:1355–60.

    CAS  PubMed  Google Scholar 

  138. Weatherhead RG. Wolfring dacryops. Ophthalmology. 1992;99:1575–81.

    CAS  PubMed  Google Scholar 

  139. Massry GG, Harrison W, Hornblass A. Clinical and computed tomographic characteristics of amyloid tumor of the lacrimal gland. Ophthalmology. 1996;103:1233–6.

    CAS  PubMed  Google Scholar 

  140. Buggage RR, Spraul CW, Wojno TH, Grossniklaus HE. Kimura disease of the orbit and ocular adnexa. Surv Ophthalmol. 1999;44:79–91.

    CAS  PubMed  Google Scholar 

  141. Kodama T, Kawamoto K. Kimura’s disease of the lacrimal gland. Acta Ophthalmol Scand. 1998;76:374–7.

    CAS  PubMed  Google Scholar 

  142. Bonavolonta G, Tranfa F, Staibano S, Di Matteo G, et al. Warthin tumor of the lacrimal gland. Am J Ophthalmol. 1997;124:857–8.

    CAS  PubMed  Google Scholar 

  143. Scott IU, Tanenbaum M, Rubin D, Lores E. Solitary fibrous tumors of the lacrimal gland fossa. Ophthalmology. 1996;103:1613–8.

    CAS  PubMed  Google Scholar 

  144. Jakobiec F, Howard G, Jones J, et al. Hemangiopericytoma of the orbit. Am J Ophthalmol. 1974;78:816.

    CAS  PubMed  Google Scholar 

  145. Boniuk M, Messmer EP, Font RL. Hemangiopericytoma of the meninges of the optic nerve: a clinicopathologic report including electron microscopic observations. Ophthalmology. 1985;92:1780–7.

    CAS  PubMed  Google Scholar 

  146. Gurney N, Chalkley T, O’Grady R. Lacrimal sac hemangiopericytoma. Am J Ophthalmol. 1971;71:757–9.

    CAS  PubMed  Google Scholar 

  147. Redmond RM, Mannor GE, Garner A, Rose GE. Lacrimal gland hemangiopericytoma. Am J Ophthalmol. 1995;119:99–100.

    CAS  PubMed  Google Scholar 

  148. Croxotto JO, Font RL. Hemangiopericytoma of the orbit. A clinicopathologic study of 30 cases. Hum Pathol. 1982;13:210–8.

    Google Scholar 

  149. Seiff SR, McFarland JE, Shorr N, Simons KB. Cavernous hemangioma of the lacrimal fossa. Ophthal Plast Reconstr Surg. 1986;2:21.

    CAS  PubMed  Google Scholar 

  150. Slem G, Ilcayto R. Hemangioma of the lacrimal glands in an adult. Ann Ophthalmol. 1972;4:77–8.

    CAS  PubMed  Google Scholar 

  151. Jordan DR, Tse DT. Herniated orbital fat. Can J Ophthalmol. 1987;22:173–7.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David T. Tse M.D., F.A.C.S. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Tse, D.T. (2012). Evaluation and Management of Lacrimal Gland Diseases. In: Black, E., Nesi, F., Calvano, C., Gladstone, G., Levine, M. (eds) Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-0971-7_58

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-0971-7_58

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-0970-0

  • Online ISBN: 978-1-4614-0971-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics